Liver Failure, AcuteHepatic EncephalopathyLiver TransplantationLiver FailureLiver DiseasesGalactosamineAcetaminophenLiverLiver, ArtificialHepatitis, Viral, HumanLiving DonorsHepatolenticular DegenerationDrug-Induced Liver InjuryThioacetamidePlasmapheresisHemoperfusionFatal OutcomeMushroom PoisoningBilirubinNordazepamMyalgiaDrug Hypersensitivity SyndromeDrug OverdoseLiver Function TestsPeliosis HepatisHepatitisLiver RegenerationTreatment OutcomeTransplantation, HomologousLiver CirrhosisGraft SurvivalAlanine TransaminaseHepatic ArteryLiver NeoplasmsPlasma ExchangeCharcoalRetrospective StudiesAspartate AminotransferasesAcute DiseaseHepatocytesProthrombin TimeHepatitis BKidney TransplantationAnalgesics, Non-NarcoticGraft RejectionTime FactorsAcanthopanaxHemofiltrationTissue DonorsBone Marrow TransplantationPrognosisPostoperative ComplicationsHepatectomyHepatic VeinsNecrosisAcute Kidney InjuryImmunosuppressive AgentsIntracranial PressureDisease Models, AnimalEnd Stage Liver DiseaseTissue and Organ ProcurementLiver CirculationHeart FailureHematopoietic Stem Cell TransplantationHeart TransplantationBrain EdemaCarcinoma, HepatocellularTransplantation, AutologousWaiting ListsPortal VeinLung TransplantationBiliary AtresiaSeverity of Illness IndexLipopolysaccharidesStem Cell TransplantationRecurrenceFatty LiverOrgan TransplantationTacrolimusTransplantationFollow-Up StudiesSurvival RateTransplantation ConditioningBacterial InfectionsTransplantation ImmunologyImmunosuppressionLiver Cirrhosis, AlcoholicTumor Necrosis Factor-alphaBiliary Tract DiseasesSurvival AnalysisPancreas TransplantationDonor SelectionBile DuctsCholestasisRisk FactorsHepatitis CMice, Inbred C57BLBudd-Chiari SyndromeIslets of Langerhans TransplantationPostoperative Period